HIV-positive TB patients on ART (antiretroviral therapy) in Pakistan
Pakistan: HIV-positive TB patients on ART (antiretroviral therapy) was 70.0% in 2024. ▼ Falling
Latest (2024)
70.0%
Change on year
up 14.8%
World rank
125th
of 144 countries
All-time high
100.0%
in 2008
All-time low
39.0%
in 2009
Years of data
17
2008–2024
HIV-positive TB patients on ART (antiretroviral therapy) in Pakistan, 2008–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, hiv-positive tb patients on art (antiretroviral therapy) in Pakistan stood at 70.0%.
Compared with earlier readings it is up 14.8% on the previous year and down 30.0% over ten years.
Over the whole period, hiv-positive tb patients on art (antiretroviral therapy) in Pakistan peaked at 100.0% in 2008 and was at its lowest, 39.0%, in 2009.
Pakistan ranks 125th of 144 countries on this measure, in the bottom quarter.
The long-run direction has been consistently falling across the 17 years of available data.
HIV-positive TB patients on ART (antiretroviral therapy) in Pakistan, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 100.0% | — |
| 2009 | 39.0% | -61.0% |
| 2010 | 43.0% | +10.3% |
| 2011 | 56.0% | +30.2% |
| 2012 | 96.0% | +71.4% |
| 2013 | 100.0% | +4.2% |
| 2014 | 100.0% | +0.0% |
| 2015 | 100.0% | +0.0% |
| 2016 | 96.0% | -4.0% |
| 2017 | 80.0% | -16.7% |
| 2018 | 66.0% | -17.5% |
| 2019 | 79.0% | +19.7% |
| 2020 | 65.0% | -17.7% |
| 2021 | 63.0% | -3.1% |
| 2022 | 79.0% | +25.4% |
| 2023 | 61.0% | -22.8% |
| 2024 | 70.0% | +14.8% |
Pakistan compared with similar countries
- Pakistan's 70.0% is below the median for lower middle income countries, which is 96.0%, 73% of the median. (43 countries reporting)
- Pakistan's 70.0% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 100.0%, 70% of the median. (19 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 69.5% | 39.0% | 100.0% | 2 |
| 2010s | 81.6% | 43.0% | 100.0% | 10 |
| 2020s | 67.6% | 61.0% | 79.0% | 5 |
Countries ranked near Pakistan
More health data for Pakistan
- Un projection of annual infant deaths, annual growth rate -2.14 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8219 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 944.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 55,286 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 335 (2025)
- Population ages 00-04, female, annual growth rate 0.5028 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0616 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.4109 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hiv-positive tb patients on art (antiretroviral therapy) in Pakistan?
- Hiv-positive tb patients on art (antiretroviral therapy) in Pakistan was 70.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hiv-positive tb patients on art (antiretroviral therapy) recorded in Pakistan?
- The highest recorded value was 100.0% in 2008.
- What is the lowest hiv-positive tb patients on art (antiretroviral therapy) recorded in Pakistan?
- The lowest recorded value was 39.0% in 2009.
- How does Pakistan rank for hiv-positive tb patients on art (antiretroviral therapy)?
- Pakistan ranks 125th out of 144 countries with data for 2024.
- Is hiv-positive tb patients on art (antiretroviral therapy) rising or falling in Pakistan?
- Over the last ten years it is down 30.0%. The long-run trend across the full record is falling.
- Where does this Pakistan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 17 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).